This study was designed to examine whether disparities exist in the demographic, clinical, and laboratory characteristics of patients with pSS who exhibit quadruple (ANA, antiSSA/Ro, antiSSB/La, and RF) antibody negativity. The gene discussed is CALR; the disease is peeling skin syndrome.